Pages that link to "Q73956703"
Jump to navigation
Jump to search
The following pages link to Effects of Postmenopausal Hormone Replacement Therapy With and Without Vitamin D3 on Circulating Levels of 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D (Q73956703):
Displaying 12 items.
- Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial (Q33790554) (← links)
- Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution (Q33909569) (← links)
- Calcium and vitamin D. Diagnostics and therapeutics. (Q34032541) (← links)
- Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies (Q35770954) (← links)
- Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23. (Q35860672) (← links)
- Vitamin D and oestrogen receptor polymorphisms in developmental dysplasia of the hip and primary protrusio acetabuli--a preliminary study (Q35906401) (← links)
- Vitamin D dose response is underestimated by Endocrine Society's Clinical Practice Guideline (Q36924517) (← links)
- Serum 25-hydroxyvitamin D concentrations and risk for hip fractures (Q37345469) (← links)
- A systematic review and meta-regression analysis of the vitamin D intake-serum 25-hydroxyvitamin D relationship to inform European recommendations (Q37945988) (← links)
- Prevention of postmenopausal bone loss with exchange for short-term HRT for 1alpha-hydroxycholecalciferol (Q44466383) (← links)
- HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial (Q74633398) (← links)
- Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it (Q77462894) (← links)